ProMIS Neurosciences, Inc. (PMN)

11.35 -0.18 (-1.56%) USD  |  NASDAQ  |  Apr 20, 15:56
More

ProMIS Neurosciences Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for PMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade